1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Tecemotide: new trials by email Literature Review of Tecemotide trials Research Report on Tecemotide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery bevacizumab, Tecemotide, carboplatin - Lung Cancer | Phase 2 | Completed | ECOG-ACRIN Cancer Research Group | 70 | 2011-01-17 | 2023-07-07 |
Adenocarcinoma of Lung (1) · Carcinoma, Non-Small-Cell Lung (1) · Lung Neoplasms (1)
ECOG-ACRIN Cancer Research Group (1)
United States (1)
Jyoti D. Patel (1)
U10CA180794 (1)